The authors found concurrent growth in pharmacy benefit manager market concentration and worsening of patient access measures across states from 2016 to 2025.
|Articles|September 1, 2000
Supplements and Featured Publications
- Implementing Optimal Guidelines for Growth Hormone Use in a Managed Care Population
- Volume 6
- Issue 15 Suppl
Introduction
Author(s)Ron Rosenfeld, MD
Advertisement
Articles in this issue
about 26 years ago
Participating Facultyabout 26 years ago
Clinical and Reimbursement Issues on Growth Hormone Use in Adultsabout 26 years ago
Clinician and Payer Issues in Managing Growth Hormone Deficiencyabout 26 years ago
CME / CPE / CCMCE Quizabout 26 years ago
Selected AbstractsAdvertisement
Related to this article
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Durvalumab Plus EV Before Surgery in Cisplatin-Ineligible MIBC
2
ObesityWeek 2026: Studies Map GLP-1 Access Gaps, Obesity's Costs
3
5 Things to Know About Diabetes-Related Eye Disease Awareness Month
4
Payers, Eosinophil Thresholds Shape Who Gets a COPD Biologic
5